Ospedale di Mantova Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00609401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ASST Mantova | Hospital "Carlo Poma" - Mantova - Italy | OSPEDALE CARLO POMA ASST MANTOVA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Neoplasm Metastasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3